Marijuana Blog

Anchorage police seize marijuana plants, computers in raid on Alaska Cannabis Club

Category: News | Posted on Sun, March, 22nd 2015 by THCFinder

Anchorage police served a search warrant on the Alaska Cannabis Club's downtown clubhouse on Friday afternoon, taking boxes of evidence from the residence as club owner Charlo Greene watched.

Anchorage Police Department spokesperson Jennifer Castro told reporters on scene later Friday afternoon that police had received reports of illegal marijuana sales occurring at the clubhouse. No charges had been filed Friday, Castro said.

Police arrived about 1 p.m., Greene said. Greene, whose legal name is Charlene Egbe, is a former television news reporter who achieved national notoriety in September when she quit on-air after announcing she was the owner of the club.

A copy of the search warrant provided by Greene specified police were searching for evidence of "misconduct involving a controlled substance." 

According to Greene, there were nine marijuana plants in one duplex and 14 in another. Five medical-marijuana cardholders live at the residence, Greene said. She said 10 to 12 medical marijuana cardholders were in the residence when the search warrant was served.

"I'm not surprised but I am disappointed," Greene said of the raid.

Two marked police cars were outside the residence on Friday afternoon, with a few more arriving as the search wore on. Greene said about seven officers were boxing up marijuana plants, computers, papers and other materials in the clubhouse. Greene said she was free to go but chose to wait while police took evidence from the home.

Read More:


A Friend With Weed Is A Friend Indeed

Category: Fun | Posted on Sat, March, 21st 2015 by THCFinder


Washington Senate Approves PTSD As Qualifying Medical Marijuana Condition

Category: Medical Marijuana | Posted on Sat, March, 21st 2015 by THCFinder

washington state capitol olympia marijuanaMedical marijuana has been found to be an effective treatment for PTSD. That’s why so many states have added PTSD to the list of qualifying conditions to become a medical marijuana patient. Washington unfortunately is not one of those states. But it does appear that PTSD has a good chance of being added to Washington State’s medical marijuana program. This week the Washington Senate approved a bill that would do just that. Per The Joint Blog:

Washington State’s full Senate, with a 48 to 0 vote, has approved a bill to add PTSD as a qualifying medical cannabis conditions.

Senate Bill 5379 was filed by Senator Steve Hobbs, an active member of the Army National Guard, and has been sent to the state’s House of Representatives. Its passage in the House will send it to Governor Jay Inslee for consideration. Nine other states – Michigan, California, Connecticut, Delaware, Maine, Massachusetts, New Mexico, Arizona and Oregon – allow those with PTSD to use cannabis for medical purposes.

No one should be denied medical marijuana if it helps treat their condition. To deny a suffering person medicine is a terrible thing, and such an act lacks compassion towards sick and suffering people. I’m happy to see this bill move forward. The bill now moves to the Washington House. I have to assume that if the bill passed unanimously in the Washington Senate, that it has a good chance of passing in the House, albeit maybe not unanimously.


Marijuana Gears Up for Production High in U.S. Labs

Category: News | Posted on Sat, March, 21st 2015 by THCFinder

Now, with legal marijuana increasingly available to the US public, NIDA is quietly working to expand the amount and variety of the drug available for study. 

Residents of 23 US states can buy medical marijuana to treat everything from cancer pain to anxiety, but US scientists must wade through onerous paperwork to score the drug for study. Their sole dealer is the National Institute on Drug Abuse (NIDA), which has a contract with the University of Mississippi in Oxford to produce marijuana for research purposes.

The agency has long faced complaints that its marijuana is too weak to represent what is sold on the street, and contains low levels of the non-psychedelic chemicals that show therapeutic promise for conditions such as epilepsy and chronic pain. Now, with legal marijuana increasingly available to the US public, NIDA is quietly changing course—working to expand the amount and variety of the drug available for study.

“We want to be able to evaluate the claims that marijuana is therapeutically beneficial” and to explore treatments for addiction, says Nora Volkow, director of NIDA in Rockville, Maryland.

In 2014, the institute increased its spending on research marijuana by 50%. Annual production at the University of Mississippi farm, where all the agency supplies are grown, soared from 18 to 600 kilograms, and the crop harvested late last year includes two new strains. One has low concentrations of tetrahydrocannabinol (THC), marijuana’s primary active ingredient, but high levels of cannabidiol, a non-hallucinogenic substance that seems to have therapeutic effects. The second has relatively balanced levels of the two chemicals.

Mahmoud ElSohly, who directs the University of Mississippi cultivation programme, says that the new strains will soon be ready to ship to researchers. But the farm’s improved offerings may not appease NIDA’s critics—including US states such as Colorado, which legalized recreational pot use in 2012. In December, the Colorado state government asked the federal government to allow state universities to grow marijuana for research, citing bureaucratic hurdles in obtaining products from NIDA and from private growers overseas.

Read More:





Blog Categories

Popular Articles

Latest Offers In Your Area
Recent Blog Posts
Download Our App!
14.4 Miles Away | LOS ANGELES,
13.4 Miles Away | Los Angeles ,
15.4 Miles Away | Anaheim,
October 12, 2015 | Category: Culture
October 12, 2015 | Category: Fun
October 12, 2015 | Category: News
Mobile Apps
Copyright 2015
All Rights Reserved.
Dispensaries      Strains      About Us      Friends      API / Widgets      Privacy Policy      Terms of Use      Investors      Contact Us